Long-Term Efficacy of Serenoa repens Treatment in Patients with Mild and Moderate Symptomatic Benign Prostatic Hyperplasia

Publisher： Karger

E-ISSN： 1423-0399|86|3|284-289

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.86, Iss.3, 2011-02, pp. : 284-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of hexanic extract of serenoa repens (permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia

By  

THE PROSTATE, Vol. 75, Iss. 16, 2015-12 ,pp. : 1857-1867

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Tamsulosin Plus Serenoa Repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study

By  

Urologia Internationalis, Vol. 94, Iss. 2, 2015-0 ,pp. : 187-193

Karger

Access to resources Recommend Favorite

Effect of Serenoa Repens on Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia

By  

PHYTOTHERAPY RESEARCH, Vol. 951-418X, Iss. 10, 2015-10 ,pp. : 1525-1531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Serenoa Repens on Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia

By  

PHYTOTHERAPY RESEARCH, Vol. 29, Iss. 10, 2015-10 ,pp. : 1525-1531

John Wiley & Sons Inc

Access to resources Recommend Favorite

Finasteride: A Long-Term Follow-Up in the Treatment of Recurrent Hematuria Associated with Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 67, Iss. 1, 2001-07 ,pp. : 69-72

Karger

Access to resources Recommend Favorite